Predictions
Medigene AG
Start price
Target price
Perf. (%)
€1.87
24.06.23
24.06.23
€1.00
24.06.24
24.06.24
-15.55%
18:06
18:06
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Salesforce.com
Start price
Target price
Perf. (%)
€192.40
24.06.23
24.06.23
€209.00
24.06.24
24.06.24
33.30%
19:14
19:14
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€90.32
24.06.23
24.06.23
€108.00
24.06.24
24.06.24
32.97%
19:15
19:15
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Low dividend yield expected
Ascendis Ph.sp.adr 1 Dk 1
Start price
Target price
Perf. (%)
€79.00
24.06.23
24.06.23
€150.00
31.08.25
31.08.25
53.16%
09.05.24
09.05.24
Could be very worthwhile Investment >20% year
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€81.00
24.06.23
24.06.23
€100.00
31.12.25
31.12.25
-14.81%
17:56
17:56
Could be very worthwhile Investment >20% year
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€85.44
24.06.23
24.06.23
€100.00
31.07.25
31.07.25
-10.86%
09.05.24
09.05.24
Could be very worthwhile Investment >20% year
Chimerix Inc.
Start price
Target price
Perf. (%)
€1.19
24.06.23
24.06.23
€3.00
31.03.26
31.03.26
-20.72%
18:10
18:10
Could be very worthwhile Investment >20% year
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€38.49
24.06.23
24.06.23
€50.00
31.03.26
31.03.26
-39.00%
18:27
18:27
Could be very worthwhile Investment >20% year
Ideaya Biosciences Inc.
Start price
Target price
Perf. (%)
€22.20
24.06.23
24.06.23
€37.00
31.12.25
31.12.25
67.57%
10.05.24
10.05.24
Could be very worthwhile Investment >20% year
Immutep LTD ADR
Start price
Target price
Perf. (%)
€1.75
24.06.23
24.06.23
€4.00
31.12.25
31.12.25
52.00%
10.05.24
10.05.24
Could be very worthwhile Investment >20% year
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€7.14
24.06.23
24.06.23
€9.00
30.11.25
30.11.25
43.35%
17:56
17:56
Could be very worthwhile Investment >20% year
Krystal Biotech
Start price
Target price
Perf. (%)
€105.00
24.06.23
24.06.23
€200.00
30.04.26
30.04.26
38.71%
09.05.24
09.05.24
Could be very worthwhile Investment >20% year
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€214.90
24.06.23
24.06.23
€380.00
31.05.26
31.05.26
-11.89%
17:40
17:40
Could be very worthwhile Investment >20% year
Merus N.v.
Start price
Target price
Perf. (%)
€23.20
24.06.23
24.06.23
€40.00
30.04.26
30.04.26
78.45%
16:45
16:45
Could be very worthwhile Investment >20% year
Prothena Corp. plc
Start price
Target price
Perf. (%)
€62.00
24.06.23
24.06.23
€90.00
31.03.26
31.03.26
-67.90%
17:05
17:05
Could be very worthwhile Investment >20% year
Legend Biotech Corp.
Start price
Target price
Perf. (%)
€66.00
24.06.23
24.06.23
€90.00
28.02.26
28.02.26
-39.09%
15:32
15:32
Could be very worthwhile Investment >20% year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€44.20
24.06.23
24.06.23
€60.00
31.12.25
31.12.25
-75.00%
10.05.24
10.05.24
Could be very worthwhile Investment >20% year
Roivant Sciences Ltd.
Start price
Target price
Perf. (%)
€9.00
24.06.23
24.06.23
€16.00
31.12.25
31.12.25
16.28%
08:00
08:00
Could be very worthwhile Investment >20% year
Schrodinger Inc.
Start price
Target price
Perf. (%)
€39.18
24.06.23
24.06.23
€100.00
31.08.26
31.08.26
-44.90%
19:04
19:04
Could be very worthwhile Investment >20% year
Vaxcyte Inc.
Start price
Target price
Perf. (%)
€49.20
24.06.23
24.06.23
€70.00
31.12.26
31.12.26
22.97%
15:49
15:49
Could be very worthwhile Investment >20% year
Verona Pharma plc ADR
Start price
Target price
Perf. (%)
€19.10
24.06.23
24.06.23
€40.00
31.12.25
31.12.25
-29.32%
16:35
16:35
Could be very worthwhile Investment >20% year
Voyager Therapeutics Inc
Start price
Target price
Perf. (%)
€10.60
24.06.23
24.06.23
€20.00
31.12.25
31.12.25
-24.86%
15:45
15:45
Could be very worthwhile Investment >20% year